WASHINGTON (Reuters) – California-based cultured meat company GOOD Meat has received approval from the U.S. Food and Drug Administration to market lab-grown chicken, according to agency documents released Tuesday.
Several companies are working to bring cultured meat to market in the United States and must obtain approval from both the FDA and the USDA before they can sell their products.
Chicken GOOD Meat is the second cultured meat product to receive a “no questions asked” letter from the FDA after California-based UPSIDE Foods received a regulatory green light for its cultured chicken breast last November. This letter signifies that the FDA accepts the company’s conclusion that its product is safe for humans.
“At this time, we have no questions regarding GOOD Meat’s conclusion that products consisting of or containing cultured chicken cell material are [are] as safe as comparable products produced by other methods,” the agency said in a March 20 letter.
GOOD Meat plans to first sell its products to restaurants owned by chef José Andrés, known for his work on global food security. Since 2020, the company has been selling its chicken in small quantities in Singapore.
“I am so proud to be able to bring this new way of cooking meat to my country and to do so alongside my idol, Chef José Andres,” Josh Tetrick, co-founder and CEO of GOOD Meat, said in a statement.
Cultured meat is obtained from a small sample of animal cells that are fed on nutrients and grown in steel vats before being processed into chunks of meat. Meat farming companies claim the product benefits the environment as it can reduce greenhouse gas emissions from livestock by 14.5% globally.
(Reporting by Leah Douglas; editing by Emilia Sithole-Matharis)